We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

71 hedge funds and large institutions have $305M invested in Collegium Pharmaceutical in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 15

76% more capital invested

Capital invested by funds: $173M → $305M (+$132M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 73 → 71 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

94% less call options, than puts

Call options by funds: $58K | Put options by funds: $963K

Holders
71
Holders Change
-2
Holders Change %
-2.74%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
27
Reduced
15
Closed
10
Calls
$58K
Puts
$963K
Net Calls
-$905K
Net Calls Change
-$910K

Top Buyers

1
CCM
Cadian Capital Management
New York
+$5.7M
2
SAM
Sectoral Asset Management
Quebec, Canada
+$4.89M
3
PHS
PFM Health Sciences
California
+$4.78M
4
RSCM
Rock Springs Capital Management
Maryland
+$3.92M
5
HCMT
Highland Capital Management (Texas)
Texas
+$1.96M

Top Sellers

1
EC
EcoR1 Capital
California
-$3.34M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$2.63M
3
AII
AGF Investments Inc
Ontario, Canada
-$1.32M
4
SM
Sabby Management
Florida
-$1.2M
5
TA
Tamarack Advisers
California
-$1.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$999K -$2.63M -221,081 -81%
BIM
27
BlackRock Investment Management
Delaware
$991K -$891 -75 -0.1%
TAM
28
Tocqueville Asset Management
New York
$980K -$11.9K -1,000 -2%
PC
29
Pier Capital
Connecticut
$861K +$531K +44,700 New
TC
30
TFS Capital
Pennsylvania
$653K -$174K -14,625 -30%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$553K +$3.56K +300 +1%
PP
32
PDT Partners
New York
$458K – – –
TA
33
Teachers Advisors
New York
$415K – – –
Charles Schwab
34
Charles Schwab
California
$411K – – –
Swiss National Bank
35
Swiss National Bank
Switzerland
$345K – – –
MWP
36
MYCIO Wealth Partners
Pennsylvania
$327K – – –
M&T Bank
37
M&T Bank
New York
$327K +$43K +3,621 +27%
ProShare Advisors
38
ProShare Advisors
Maryland
$312K -$35.6K -2,999 -16%
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$296K +$44.5K +3,750 +32%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$266K – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$236K +$2.38K +200 +2%
SCM
42
Sterling Capital Management
North Carolina
$231K +$143K +12,000 New
CS
43
Credit Suisse
Switzerland
$228K -$186K -15,643 -57%
Goldman Sachs
44
Goldman Sachs
New York
$222K -$387K -32,542 -74%
AllianceBernstein
45
AllianceBernstein
Tennessee
$218K +$11.9K +1,000 +10%
Barclays
46
Barclays
United Kingdom
$218K +$131K +10,994 +3,501%
Wells Fargo
47
Wells Fargo
California
$171K +$81.9K +6,897 +350%
NFA
48
Nationwide Fund Advisors
Ohio
$167K – – –
TG
49
TLP Group
Illinois
$164K +$101K +8,500 New
AIG
50
American International Group
New York
$150K +$131 +11 +0.1%
1
2
3 4

COLL Hedge Fund Activity: Q3 2016 in Review

71 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2016, worth a combined $305M — up 76% from $173M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of COLL and 8 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 27 added.

The largest buyer was Cadian Capital Management, opening a new position worth an estimated $5.7M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $3.34M sold.

  • 71 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2016, down from 73 in Q2 2016.
  • Funds reported $305M of Collegium Pharmaceutical stock for Q3 2016, up 76% quarter-over-quarter.
  • 8 funds opened new Collegium Pharmaceutical positions in Q3 2016 and 10 closed out, a net change of -2 holders.
  • The largest Collegium Pharmaceutical buyer in Q3 2016 was Cadian Capital Management, an estimated $5.7M added.
  • The largest Collegium Pharmaceutical seller in Q3 2016 was EcoR1 Capital, an estimated $3.34M sold.

Based on aggregated 13F filings for Q3 2016.